GENERAL COMMENTS
I would like to thank the authors for being given the opportunity to review their study proposal for assessing "…Differences in Access to Emergency Paediatric Intensive Care and care during Transport (DEPICT)".
A few questions in regards the study design:
• For the sake of clarity could you please describe the patient population transported by PICRTs in the UK (are any neonates included; what is the upper age range)? • I was unclear whether the study also analyzes the transport of children to adult ICUs? Under study dataset you describe using CMP data in regards children admitted to adult critical care units.
• If children are transported by non-PICRTs, are their cases examined as well? I understand that there are time sensitive transports/ admissions (eg. Traumatic brain injury) that might not be transported by a PICRT in some regions of the UK. Analyzing these cases will help inform the modelling of transport teams/ composition/ placement etc.
• When "time from referral call to time of arrival at bedside" is analyzed, are transport times collected separately (to account for distinct transport distances/ durations)? Likewise, is stabilization time accounted for separately as part of the "referral call to ICU admission" time (to account for stabilization time as opposed to delayed PICU access/ bed availability)? These are obvious confounders that are important to account for in your analysis.
• When analyzing for associations with outcomes, are you also comparing these associations to those that might be seen in non-transported patients? It may be that any disease-related associations more reflect the underlying pathophysiology as opposed to any transport effect.
•
This might be a level of complexity that is impossible to capture in this kind of study, but…Many teams likely provide care that is different based upon the kind of subspecialty program that is in their local setting (eg. a pediatric transplant centre, or congenital heart surgical centre). Are these differences in team 'structure/ training/ expertise' (ie. Model) going to be captured in some way in the qualitative part of your study (Work stream B)? • Part of modeling for transport systems includes having an understanding of not just transport volume, but number of simultaneous/ overlapping referral calls/ transport dispatches. Is this data being captured/ analyzed in the study (I see that you will discuss it in your modelling, but will you have any data from which to work)?
REVIEWER
Jim Marcin UC Davis, USA REVIEW RETURNED 21-Dec-2018
GENERAL COMMENTS
This is a very well written and organized manuscript describing the study evaluating the differences in access to Emergency Pediatric Intensive Care and care during Transport
REVIEWER

Peter Watson
University of Cambridge UK REVIEW RETURNED 29-Jan-2019
GENERAL COMMENTS
Differences in access to Emergency Paediatric Intensive Care and care during Transport (DEPICT): study protocol bmjopen-2018-028000
I find this protocol a little vague and confusing as to what hypotheses are being tested and which variables are involved in these hypotheses. I also find the description of the modelling approaches in places somewhat vague (e.g. Page 18, lines 20-40 "we will also combine the results of this modelling strand with the cost-effectiveness analysis..." I'm afraid it is not clear to me from that paragraph how this would be done. I am not convinced that a clinician reading this paper would be able to reproduce the cost effectiveness and minimisation of "time from bedside" analyses described in this paragraph.
I also would like to see further details about how the analysis will deal with clustered cases and which clusters will be adjusted for. I also think the confounders and auxiliary variables for use in imputation can be identified and stated in the protocol solely using clinical discussion rather than relying on any analysis since one would be using the data twice in these cases (once to identify confounders and auxiliary variables to be used in imputation if missingness > 10% (line 40 on page 31) and then a second time using the confounders and auxiliary variables identified in the first analysis which has different aims to the initial analysis).
I am not convinced the best place to put a statistical analysis plan is in an appendix. The contents of the appendix on page 31 line 37-51 and page 32 lines 10-33 could more naturally be placed in a traditional Methods section within the main body of the paper. You could also add into the paper which confounders and auxiliary variables the clinicians have decided (prior to any analysis or indeed data collection) are to be used in the regression and imputation models.
Page 8, lines 55-56 and Page 24, line 35. Within 30-day mortality (primary outcome) and mortality at PICU discharge are flagged as outcomes. I assume these are 0/1 variables which it is proposed to analyse using a logistic model (page 10, lines 23-25) but a better analysis might be a survival analysis taking into account when a person actually died with non-deaths counting as censored outcomes as you seem to be observing these people over the 30 days after admission? This analysis uses more information than the 0/1 logistic approach. I notice you mention survival analysis (page 10, line 13) for "length of stay" but this is just for secondary outcomes.
Page 10, line 6. I may be slow here but I don't see how you can assess the effect of an unmeasured confounder. If you have no data you can't assess it.
Page 10, lines 23-25 I wonder whether the description of the logistic regressions should state that they are comparing PROPORTIONS of people re-admitted to A&E to adjust for different total frequencies across whatever is being compared e.g. PICRTs. Similarly you should state that Poisson is comparing the RATE of readmissions to take into account the same differences in total frequencies perhaps using an offset term. In other words saying you have 1000 readmissions may be a small rate of readmission in busier hospitals which handles many thousands of people compared to say 5 readmissions in a less busy hospital where the '5' represents a larger proportion of possible readmissions depite being lower in magnitude.
Page 10, lines 31-43. I assume that the power calculation is comparing differences in mortality rates with reaching the patient in 3 hours or less? I did a power calculation comparing binomial proportions which showed me that you do have ample power but should you also be take clustering into account in the power calculation e.g. are these different children who are critically ill or repeated readmissions of the same children? I also wondered when doing such a comparison (mortality rate with time to reach patient) would you in addition also be adjusting for confounders such as geographical location where perhaps outlying areas which may, say, take longer to reach be more affluent and so may be able to afford better homecare and local treatments for critically ill children than those in the city centres?
Page 10, line 51. Why won't p-values be presented? This implies that the interest is in computing effect sizes rather than statistical testing to find differences or correlations. Is this correct? What are the odds ratios and risk ratios (page 10, line 49) testing? Is this comparing whether ever re-admission to A&E (page 10, line 23) varies across levels of other predictors adjusted for other predictors such as those mentioned in Figure 1 on page 24, lines 40-43? I feel it would be easier to understand and more natural to say at least what some of the hypotheses are that are being tested in the text when the effect sizes are first presented or give a mention to where more details are located in the paper. Page 24. Figure 1 . There is likely to be a lot of clustering in this study due to patients in the study coming from the same hospital, PICRT, rural/geographic location, even possibly from the same family. This creates a dependency in the data which needs to be taken into account. There is a single mention of multilevel modelling (lines 40-42 on page 24) with no further details. Is it proposed for the multilevel analysis to take account of clustering effects e.g. by fitting variance components and, if so, which clustering effects will be taken into account? I assume, therefore, that multilevel poisson, negative binomial and/or binomial models will be fitted to account for the clustering. If so this should be explicitly stated in the text on page 10, lines 13-26 which does not mention models that will take account for clustered data.
Page 31, lines 37-50. How does imputing for scores (e.g. PIM scores) not missing at random differ from imputing for scores missing at random? The variables to be used in any imputation I feel should be decided apriori by clinicians rather than decided by the data to see which variables are related to the missingness. Using the data rather than clinicians to decide things risks data snooping where spurious results occurring by chance can be misleadingly flagged. One is using the data twice -once to identify auxiliary variables in imputations and a second time to use them to estimate missing values in an imputed regression analysis.
REVIEWER
Sungchul Park
Drexel University, USA REVIEW RETURNED 18-Feb-2019
GENERAL COMMENTS
This study aims to explore the following two questions: 1) how clinical outcomes of critically ill children transported to pediatric intensive care (PIC) are affected by variations in both timeliness of access to PIC and the care provided by PIC retrieval teams during stabilization and transport and 2) the experience of the transport of critically ill children from the perspectives of different stakeholders. It plans to perform in five ways: 1) work stream A (quantitative analysis using linked data from routine clinical audit and administrative sources), 2) work stream B (prospective observational study using surveys), 3) work stream C (health economic evaluation), 4) work stream D (mathematical modelling), and 5) work stream E (synthesis of findings from the four work streams).
This study tries to answer an important research question, but it does not provide sufficient information on sample, statistical analysis, and limitations. This is excessive and thus I am not sure whether findings from this study will be reliable and produce meaningful and valid evidence. Thus, I recommend to reject this manuscript. Detailed comments are as follows:
Work stream A • The study does not describe how to exclude ineligible populations. Will all children transported emergency admissions to UK PICUs be included?
• The study does not describe how to deal with missing data. Will missing data be removed from analysis?
• The study aims to examine seven secondary outcomes, but it is unclear why those outcomes were investigated. Please add each hypothesis in order to understand the purpose of the analysis.
• The study does not cite any papers in explaining potential confounding variables and statistical analysis. Thus, it is unknown whether confounding variables described in the manuscript are acceptable or scientific.
• The study aims to examine various analyses such as multilevel analysis, instrumental variable analysis, and sensitivity analysis. However, they are not fully explained in the manuscript.
• The study aims to use a negative binomial model to examine resource use in PICU and hospital resource use following PICU discharge. However, it is well known that the model is subjective to overdispersion.
• This study lacks limitations and thus this leads me to wonder whether authors are aware of data sets and whether they have thought about how to address limitations.
Work stream B
• This study does not provide detailed information about interview questions. Thus, it is hard to see the value of the work stream B.
• This study described how to analyze data, but it is still unclear and ambiguous. It needs to provide explain more, for example, thematic analysis and framework.
• This study lacks limitations. For example, it expects a return rate of 25 percent. However, findings from the data could be generalizable? Also, will missing data be removed from analysis?
Work stream C • This study describes "this will utilise the datasets created in work streams A and B", but lacks how the dataset from work stream B is used.
• This study unclearly describes costs and it needs to explain the outcome variable. For example, what are societal costs in this context and how are they measured?
• This study described how to deal with selection bias, but it is still unclear and ambiguous. It needs to provide explain more.
Work stream D • The study aims to examine various analyses such as mathematical modeling and optimization methods. However, they are not fully explained in the manuscript. For example, how to account for seasonal allocations of teams or changes to team composition and how to develop and validate a model. If the model is not validated, then it will raise a critical question about findings.
• This study lacks limitations.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 • For the sake of clarity could you please describe the patient population transported by PICRTs in the UK (are any neonates included; what is the upper age range)? >> In work stream A, we are only including children under 16 years old (i.e. before their 16th birthday). This has been added to the Setting section and we have included a paragraph on inclusion/exclusion criteria. We will exclude transports to PICU performed by neonatal transport teams and those performed by local/non-specialist teams, but transports of neonates by paediatric retrieval teams will be ncluded. In work stream B, we will recruit parents of all transported children (<16 years old) admitted in an emergency to PICUs in England and Wales in 2018, including those transported by non-specialist and neonatal teams, to complete transport questionnaires.
• I was unclear whether the study also analyzes the transport of children to adult ICUs? Under study dataset you describe using CMP data in regards children admitted to adult critical care units. >> The study investigates children transported to PICUs who may have received prior care (e.g. stabilisation) in an adult ICU before transport. We have clarified this in the paragraph where we discuss the adult intensive care audit database.
• If children are transported by non-PICRTs, are their cases examined as well? I understand that there are time sensitive transports/ admissions (eg. Traumatic brain injury) that might not be transported by a PICRT in some regions of the UK. Analyzing these cases will help inform the modelling of transport teams/ composition/ placement etc. >> In workstream A we will consider transports by PICRTs and teams formed from PICU staff (commonly used before the conception of PICRTs), but not transports by non-specialist teams, as these are not required to meet the same standards (e.g. arrival within three hours) and do not have the same expertise. In addition, since non-specialist teams do not submit data to PICANet, detailed data on timings are not available for analysis. In Workstream B, all parents of transported children will be invited to participate for ease of recruitment but we will identify the transport teams (labelling the specific PICRT, specialist other e.g. neonatal team or non-specialist team) so we can run specific team analyses. In Workstream D, we are modelling only the location of specialist retrieval teams to best meet the demand for transport from local hospitals.
• When "time from referral call to time of arrival at bedside" is analyzed, are transport times collected separately (to account for distinct transport distances/ durations)? Likewise, is stabilization time accounted for separately as part of the "referral call to ICU admission" time (to account for stabilization time as opposed to delayed PICU access/ bed availability)? These are obvious confounders that are important to account for in your analysis. >> All transport times are collected as part of PICANet including: time of referral; time when transport was agreed; time when team departed base; time when the team arrived at the referring hospital; and time when the team arrived on the PICU. These times will be analysed as part of the study. The entire PICANet transport dataset is available here: https://www.picanet.org.uk/wpcontent/uploads/sites/25/2018/05/PICANet-form-transport-v2.1-2017-10.pdf. We have added a sentence to clarify this in the Analysis section.
• When analyzing for associations with outcomes, are you also comparing these associations to those that might be seen in non-transported patients? It may be that any disease-related associations more reflect the underlying pathophysiology as opposed to any transport effect. >> The primary aim of this study is to investigate the outcomes of transported children, although a comparison with non-transported children is an analysis which have considered, and will perform, following completion of the primary aim of the study.
• This might be a level of complexity that is impossible to capture in this kind of study, but…Many teams likely provide care that is different based upon the kind of subspecialty program that is in their local setting (eg. a pediatric transplant centre, or congenital heart surgical centre). Are these differences in team 'structure/ training/ expertise' (ie. Model) going to be captured in some way in the qualitative part of your study (Work stream B)? >> We agree with the reviewer that analysing such complex differences between teams might be challenging. During the qualitative study, we will purposively sample clinicians from different PICRT s (and models) to gather information regarding their clinical practice and experience, which will be integrated with findings from the other work streams at the final stage in workshops (work stream E). Staff will be interviewed from all 9 PICRTs, and 2 participants from each PICRT will be interviewed.
• Part of modeling for transport systems includes having an understanding of not just transport volume, but number of simultaneous/ overlapping referral calls/ transport dispatches. Is this data being captured/ analyzed in the study (I see that you will discuss it in your modelling, but will you have any data from which to work)? >> PICAnet does capture time of acceptance of referral and then time the team left on the transport which should capture waits when there is no team available, however we acknowledge that the time of acceptance of referral is not always accurately recorded.
Reviewer: 2 -This is a very well written and organized manuscript describing the study evaluating the differences in access to Emergency Pediatric Intensive Care and care during Transport >> We thank the reviewer for this positive assessment.
Reviewer: 3 -I find this protocol a little vague and confusing as to what hypotheses are being tested and which variables are involved in these hypotheses. I also find the description of the modelling approaches in places somewhat vague (e.g. Page 18, lines 20-40 "we will also combine the results of this modelling strand with the cost-effectiveness analysis..." I'm afraid it is not clear to me from that paragraph how this would be done. I am not convinced that a clinician reading this paper would be able to reproduce the cost effectiveness and minimisation of "time from bedside" analyses described in this paragraph. >> We have rewritten that sentence to be clearer: "We will also combine the results of this modelling strand with the cost-effectiveness analysis, by estimating the costs associated with different service configurations and the anticipated cost of outcomes associated with that configuration (for instance if longer journey times lead to poorer clinical outcomes)." In addition, we recognise that the statistical analysis plan was previously included in the Appendix, which was as per the Journal's request, and this may have led to lack of clarity regarding the variables and hypotheses. By bringing in the statistical analysis into the main article, we hope there is more clarity.
-I also would like to see further details about how the analysis will deal with clustered cases and which clusters will be adjusted for. I also think the confounders and auxiliary variables for use in imputation can be identified and stated in the protocol solely using clinical discussion rather than relying on any analysis since one would be using the data twice in these cases (once to identify confounders and auxiliary variables to be used in imputation if missingness > 10% (line 40 on page 31) and then a second time using the confounders and auxiliary variables identified in the first analysis which has different aims to the initial analysis). >> Within this study there may be clustering due to patients being transported more than once and also potential clustering within the transport teams. We have added clarification around this to the Analysis section. We have also clarified the missing data section -as explained, the decision of how to approach the multiple imputation will be undertaken by the entire Study Management Group which includes clinicians, methodologists and parent representatives.
-I am not convinced the best place to put a statistical analysis plan is in an appendix. The contents of the appendix on page 31 line 37-51 and page 32 lines 10-33 could more naturally be placed in a traditional Methods section within the main body of the paper. You could also add into the paper which confounders and auxiliary variables the clinicians have decided (prior to any analysis or indeed data collection) are to be used in the regression and imputation models. >> After clarifying word limits with the editor, we have moved the content of the appendix into the main manuscript. The full statistical analysis plan is also available on the study website (https://depictstudy.org.uk/study-documents). The list of confounders is provided in Table 1 .
-Page 8, lines 55-56 and Page 24, line 35. Within 30-day mortality (primary outcome) and mortality at PICU discharge are flagged as outcomes. I assume these are 0/1 variables which it is proposed to analyse using a logistic model (page 10, lines 23-25) but a better analysis might be a survival analysis taking into account when a person actually died with non-deaths counting as censored outcomes as you seem to be observing these people over the 30 days after admission? This analysis uses more information than the 0/1 logistic approach. I notice you mention survival analysis (page 10, line 13) for "length of stay" but this is just for secondary outcomes. >> Survival analysis is not necessary for the primary analysis, as we are not interested in time to event (i.e. death). We have proposed using it for length of stay as time to event (i.e. discharge/death) is of direct interest in that secondary analysis.
-Page 10, line 6. I may be slow here but I don't see how you can assess the effect of an unmeasured confounder. If you have no data you can't assess it. >> We will use an instrumental variables approach as a sensitivity analysis, a well-established technique for investigating the impact of unmeasured confounders (reference 9: now provided in the revision). We will compare the sensitivity analysis to the original analysis to consider the differences in results.
-Page 10, lines 23-25 I wonder whether the description of the logistic regressions should state that they are comparing PROPORTIONS of people re-admitted to A&E to adjust for different total frequencies across whatever is being compared e.g. PICRTs. Similarly you should state that Poisson is comparing the RATE of readmissions to take into account the same differences in total frequencies perhaps using an offset term. In other words saying you have 1000 readmissions may be a small rate of readmission in busier hospitals which handles many thousands of people compared to say 5 readmissions in a less busy hospital where the '5' represents a larger proportion of possible readmissions depite being lower in magnitude. >> In both logistic and Poisson regression modelling, the outcome being modelled is (respectively) a binary and a count, and it is standard practice to refer to the binary or count outcome when discussing such models.
-Page 10, lines 31-43. I assume that the power calculation is comparing differences in mortality rates with reaching the patient in 3 hours or less? I did a power calculation comparing binomial proportions which showed me that you do have ample power but should you also be take clustering into account in the power calculation e.g. are these different children who are critically ill or repeated readmissions of the same children? >> Whilst we have provided a power calculation, our sample is constrained by the data which is available to us. We will use all available data, so to an extent the important issue is the number of adjustments which can be sensibly made rather than the power since we cannot increase the sample size. We have clarified this in the sample size section. As the reviewer noted, the available dataset is large enough to provide more than ample power.
-I also wondered when doing such a comparison (mortality rate with time to reach patient) would you in addition also be adjusting for confounders such as geographical location where perhaps outlying areas which may, say, take longer to reach be more affluent and so may be able to afford better homecare and local treatments for critically ill children than those in the city centres? >> We are going to account for patient deprivation (calculated at the level of a postcode, so a small geographical area) in the regression modelling. This has been listed in Table 1 . We note that in the UK there is no reason to suspect that health care resources are more substantial in outlying areas.
-Page 10, line 51. Why won't p-values be presented? This implies that the interest is in computing effect sizes rather than statistical testing to find differences or correlations. Is this correct? What are the odds ratios and risk ratios (page 10, line 49) testing? Is this comparing whether ever re-admission to A&E (page 10, line 23) varies across levels of other predictors adjusted for other predictors such as those mentioned in Figure 1 on page 24, lines 40-43? I feel it would be easier to understand and more natural to say at least what some of the hypotheses are that are being tested in the text when the effect sizes are first presented or give a mention to where more details are located in the paper. >> In line with recent statistical practice & discussion (e.g. https://www.nature.com/articles/d41586-019-00857-9), we feel that too much emphasis can be placed on statistical significance rather than clinical significance. We have added this to the reporting conventions section. We have provided an example of the odds ratio interpretation in the 'formal statistical analysis' section.
-Page 14, lines 54-58. How will data be compared within cases (people, PICRTs) and across cases? Not sure what you are comparing when doing analyses within people. What are across case analyses? Are these looking at the PICRTs separately or comparing odds ratios across PICRTs? >> The intention is to not directly compare the PICRTs as they should aim to perform in the same way, reaching the child's bedside within three hours, although we accept some differences may exist. This may be apparent for the teams travelling longer distances and the mathematical modelling will consider this. However, if desired we can account for the different transport teams with clustering or multilevel models. We anticipate that most patients will only experience one transport event. For patients with multiple transports there are different approaches we can take including: consider all transports as independent; only consider their last transport or cluster on patient identifier to inflate the standard errors. We will use robust sensitivity analyses to investigate the impact of our assumptions. We have added this to the manuscript.
Page 18, lines 38-40. "Explore how best to incorporate seasonal demand" is mentioned which implies to me that an aim of the analysis is to identify which function of the seasonal components gives the best predictions. Not sure from this how this is done but is this related to the use of fractional polynomials and splines (page 32, lines 23-28) where you are seeing which of these approaches gives the better fit? >> This aspect of the project (in Workstream D) is not related to the use of fractional polynomials and splines in workstream A. The mathematical modelling in Workstream D is not statistical modelling -it is a form of optimisation modelling where the aim is to minimise an objective function (specifying "costs" (e.g. journey time) attached to decisions (location of retrieval teams)) subject to various constraints (e.g. maximum number of retrieval team locations, minimum level of demand per location etc). We have the empirical demand data from PICANet and can use that to generate an empirical distribution of demand by month of year. We will firstly assess the impact of seasonal demand by calculating the outcomes of the location modelling for the different seasons (i.e. how is mean time to bedside affected during winter compared to summer) and then by allowing a different allocation of retrieval team locations depending on the time of year (which would be incorporated by changing the objective function and constraints).
Page 18, line 45. "Deciding where best to local PICRTs also needs.." doesn't seem grammatically correct. >> We have amended "local" to "locate" -thank you for spotting this typo.
Page 18, lines 47-49. Is there a reference for the queueing theory work of Pagel? >> The reference is to the queuing work of Larson -it is not our work. We would be applying methods developed by other researchers to combine queuing theory with location-allocation optimisation.
Page 24. Figure 1 . There is likely to be a lot of clustering in this study due to patients in the study coming from the same hospital, PICRT, rural/geographic location, even possibly from the same family. This creates a dependency in the data which needs to be taken into account. There is a single mention of multilevel modelling (lines 40-42 on page 24) with no further details. Is it proposed for the multilevel analysis to take account of clustering effects e.g. by fitting variance components and, if so, which clustering effects will be taken into account? I assume, therefore, that multilevel poisson, negative binomial and/or binomial models will be fitted to account for the clustering. If so this should be explicitly stated in the text on page 10, lines 13-26 which does not mention models that will take account for clustered data. >> We have added a note about the consideration of multilevel models or methods to account for clustering in the 'formal statistical analysis' section.
>> We have removed the sentence about PIM scores as this was unclear. Selection of the variables to be used in the imputation will be undertaken by the Study Management Group as previously explained. This was previously in the Appendix which has now been incorporated into the main document.
Reviewer: 4 Unless I have a misunderstanding, it seems to me that there may be clustering due to PICRTs; i.e., outcomes arising from the same PICRT may be statistically correlated. Please account for this issue in analyses if I am correct. >> We will cluster, if required, on the different transport teams. We have added this to the analysis section.
Reviewer: 5 This paper includes all necessary information, and the methods and protocols introduced are relevant. >> We thank the reviewer for this positive assessment.
Reviewer: 6
Work stream A • The study does not describe how to exclude ineligible populations. Will all children transported emergency admissions to UK PICUs be included? >> We have added a Study Population section to clarify this.
• The study does not describe how to deal with missing data. Will missing data be removed from analysis? >> We have moved the details of the statistical analysis plan from the appendix to the main paper. Missing data is now discussed in its own section within workstream A.
• The study aims to examine seven secondary outcomes, but it is unclear why those outcomes were investigated. Please add each hypothesis in order to understand the purpose of the analysis. >> We have selected secondary outcomes that are commonly used in paediatric intensive care research such as mortality at PICU discharge, length of PICU stay, organ support interventions and hospital admissions in the 12 months after PICU discharge, based on discussions with the clinical representatives in the study management group. These secondary outcomes were chosen to provide information to complement the primary outcome of 30-day mortality. We have added some clarification in the Methods >> Outcomes section.
• The study does not cite any papers in explaining potential confounding variables and statistical analysis. Thus, it is unknown whether confounding variables described in the manuscript are acceptable or scientific. >> The selection of potential confounders for the statistical analysis was performed through discussion at the study management group which comprises clinicians, statisticians and patient representatives (parents). Candidate confounders were identified through knowledge of existing literature as well as clinical experience and their potential relationship with the outcomes of interest were assessed by means of DAGs as described in the revised Methods. The literature in the area of transport is scarce, however most variables that have been assessed in previous studies have been included within the list in Table 1 .
• The study aims to examine various analyses such as multi-level analysis, instrumental variable analysis, and sensitivity analysis. However, they are not fully explained in the manuscript.
>> Due to limitation of words, we have now provided a link to the statistical analysis plan on the study website for additional information (https://depict-study.org.uk/study-documents).
• The study aims to use a negative binomial model to examine resource use in PICU and hospital resource use following PICU discharge. However, it is well known that the model is subjective to overdispersion. >> These are models which we are proposing using, having not seen the data. We will investigate if issues such as over-dispersion are issues when we use this approach. All proposed methods have assumptions (e.g. survival analysis may assume proportional hazards). We have added in a sentence to make explicit that any model assumptions will be checked.
• This study lacks limitations and thus this leads me to wonder whether authors are aware of data sets and whether they have thought about how to address limitations. >> The study team, including the statistician, are familiar with the datasets proposed. We will outline limitations in published articles. We have added a sentence to the strengths and limitations section regarding the expected limitations.
Work stream B • This study does not provide detailed information about interview questions. Thus, it is hard to see the value of the work stream B. >> Due to word limit restrictions we have not added the Topic Guides in the main article but have included them as Supplementary Material.
• This study described how to analyze data, but it is still unclear and ambiguous. It needs to provide explain more, for example, thematic analysis and framework. >> We recognise the brevity of the description of the Framework method, but feel it is appropriate given the word limit of the protocol paper. We cited a key reference in our description which gives an interested reader a source to find out more about how Framework is conducted.
• This study lacks limitations. For example, it expects a return rate of 25 percent. However, findings from the data could be generalizable? Also, will missing data be removed from analysis? >> As a protocol paper, we are unable to describe limitations of the study data which has yet to be collected. We will outline limitations in published articles. We have also added a sentence to the strengths and limitations section regarding the expected limitations.
However, for clarity, we do recognise that a low return rate for questionnaires might introduce bias in the findings and affect generalisability. We have changed the wording in the Methods description to highlight this. An assessment of the impact of missing data will be made by repeating analyses with and without participants with missing data. It is possible we may impute values or delete variables once we assess whether missing data is random or systematic.
Work stream C • This study describes "this will utilise the datasets created in work streams A and B", but lacks how the dataset from work stream B is used. >> When describing the processes for measuring costs and outcomes in Workstream C, we have now clearly articulated which data will come from workstream A and which from workstream B.
• This study unclearly describes costs and it needs to explain the outcome variable. For example, what are societal costs in this context and how are they measured? >> We have now described the cost and outcomes variables in more details, including how societal costs will be computed.
• This study described how to deal with selection bias, but it is still unclear and ambiguous. It needs to provide explain more. >> We have explained in more detail how in the economic analysis we will explore the potential for selection bias in the analysis.
Work stream D • The study aims to examine various analyses such as mathematical modeling and optimization methods. However, they are not fully explained in the manuscript. For example, how to account for seasonal allocations of teams or changes to team composition and how to develop and validate a model. If the model is not validated, then it will raise a critical question about findings. >> The mathematical modelling in Workstream D is not statistical modelling -it is a form of optimisation modelling where the aim is to minimise an objective function (specifying "costs" (e.g. journey time) attached to decisions (location of retrieval teams)) subject to various constraints (e.g. maximum number of retrieval team locations, minimum level of demand per location etc). In simple optimisation models there are exact solutions. For more complex problems that are computationally complex, heuristic algorithms are used to obtain a solution. There is no formal statistical validation of these models (and no parallel concept of validation in a new data set) -instead, sensitivity analysis is carried to out to understand the impact of small changes to the objective function, its coefficients and constraints on the resulting output (location and numbers of PICRTs). This provides an assessment of the robustness of the modelling approach to this problem. We have clarified this in the second paragraph of the Workstream D section.
• This study lacks limitations. >> We will outline limitations in detail in published articles. However, we have added a sentence to the strengths and limitations section regarding the expected limitations. Page 10 Section 4.2 Sample size in the DEPICT Statistical analysis plan pdf on the website mentioned on lines 43-45 of page 8 and page 11 Sample Size. Reading this section I wonder if a power analysis is possible to do. This is because We do not know either how many transports will be sampled as this is outside our control or how many of these transports will relate to a single child and as the authors state on page 10 in the statistical analysis pdf the power calculation is for the number of transports for separate children. The 4% (Page 11, line 36) used as the effect size change in the power calculation is also not referenced nor is the anticipated number of 15,000 transports (page 11, line 31).
VERSION 2 -REVIEW REVIEWER
I think you either admit it is not possible to work out a sample size to power this study since you don't know the numbers of transports you will be getting or what corresponds to a meaningful reduction in mortality rate or you give a reference for the anticipated number of transports based upon separate children and also reference where the 4% (page 11, line 36) comes from.
REVIEWER
Allan de Caen
Stollery Children's Hospital, University of Alberta, Edmonton, Canada REVIEW RETURNED 28-Apr-2019
GENERAL COMMENTS
My questions/ concerns have been addressed. Look forward to the completion and publishing of this study.
VERSION 2 -AUTHOR RESPONSE
Thank you to the reviewer for taking the time to review this revised manuscript. We have responded to their queries as follows:
Page 10, lines 36-38. I agree that you could use only the most recent transport to ensure all the transports are based upon different children. If you do, however, decide to use cluster as a variable in the analysis you should add in the text here that you would treat it as a random effect and use a general or generalised linear mixed model. I do see a reference in the statistical analysis plan on page 14 to such models but a few extra words in the text of the protocol paper itself would be helpful and further clarify their use.
>> We have adjusted this sentence.
I don't understand what an 'adjustment' is as mentioned on page 10 of the sample size section 4.2 in the DEPICT Statistical analysis plan pdf. Is this removing transports based upon the same child? If so as mentioned above, as in the text on page 10, line 36 all but the most recent occurrences of such transports should be removed.
Page 10 Section 4.2 Sample size in the DEPICT Statistical analysis plan pdf on the website mentioned on lines 43-45 of page 8 and page 11 Sample Size. Reading this section I wonder if a power analysis is possible to do. This is because We do not know either how many transports will be sampled as this is outside our control or how many of these transports will relate to a single child and as the authors state on page 10 in the statistical analysis pdf the power calculation is for the number of transports for separate children. The 4% (Page 11, line 36) used as the effect size change in the power calculation is also not referenced nor is the anticipated number of 15,000 transports (page 11, line 31).
>> The above comments all relate to queries around the sample size. We anticipated a sample size of 10,000-15,000 transports as this is similar to that seen in the PICANet Annual Report (see Table T1 at: https://www.picanet.org.uk/annual-reporting-and-publications/). We provided the power calculation to indicate this would provide appropriate power to undertake the analysis. Upon reflection we agree with the reviewer and therefore we have removed most of the detail from this section, and we hope this addresses the reviewers concerns.
